The Trump administration's latest healthcare efforts, namely its kidney care initiatives and a planned executive order on drug pricing, are at odds with its moves in court to obliterate the ACA, The New York Times reports.
The report notes that these reforms are possible because of the ACA and the Center for Medicare and Medicaid Innovation that runs healthcare innovation models, from ACOs to bundled payments. If the Fifth Circuit Court of Appeals rules the ACA unconstitutional, the CMMI would effectively be eliminated.
However, The Times notes the Trump administration has a plan for this, citing an interview with CMS Administrator Seema Verma by Bloomberg News. "The idea here is to keep what's working," she told Bloomberg. She did not elaborate on details of the plan.
Read more here.
More articles on leadership and management:
Former biotech exec and cancer advocate Michael Becker dies at 50
Mount Carmel CEO to resign; 23 employees fired after patient deaths investigation
Cleveland Clinic's Semih Sen on business growth in healthcare and why it's a challenge